Use of Baloxavir Marboxil Post-Exposure Prophylaxis to Halt an Influenza A(H3) Outbreak in a College Sports Team, November 2024
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciaf148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Noah Kojima und 10 weiteren Autor:innen. Beteiligte Einrichtung: Los Angeles County Department of Public Health, Community and Field Services Division, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Influenza, Human, Post-Exposure Prophylaxis, Antiviral Agents, Dibenzothiepins. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Epidemiology and Laboratory Capacity Program (grant, cooperative agreement, Public Health Emergency Preparedness Program (cooperative agreement.
Abstract (Originalsprache)
Baloxavir marboxil is approved for influenza treatment and post-exposure prophylaxis (PEP). There are limited real-world examples of its use in influenza outbreaks. Here, we describe the use of baloxavir marboxil as PEP to halt an influenza outbreak among a college sports team during the 2024–2025 influenza season.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Los Angeles County Department of Public Health, Community and Field Services Division, Los Angeles, California, USA.
- Los Angeles County Department of Public Health, Acute Communicable Diseases Control Program, Los Angeles, California, USA.
- Los Angeles County Department of Public Health, Public Health Laboratory, Los Angeles, California, USA.
ORCID-Profile: Noah Kojima, Annabelle de St Maurice, Allison Joyce
Förderung
- Epidemiology and Laboratory Capacity Program (grant
- cooperative agreement
- Public Health Emergency Preparedness Program (cooperative agreement
- CDC
Zitieren
APA
Kojima, N., de St Maurice, A., Erezo, E. J., Yanez, E., Traub, E., Joyce, A., Marutani, A., Green, N., Balter, S., Poitier, S. R., & King, J. (2026). Use of Baloxavir Marboxil Post-Exposure Prophylaxis to Halt an Influenza A(H3) Outbreak in a College Sports Team, November 2024. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf148
Vancouver
Kojima N, de St Maurice A, Erezo EJ, Yanez E, Traub E, Joyce A, et al. Use of Baloxavir Marboxil Post-Exposure Prophylaxis to Halt an Influenza A(H3) Outbreak in a College Sports Team, November 2024. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf148
BibTeX
@article{Kojima2026,
author = {Kojima, Noah and de St Maurice, Annabelle and Erezo, Earl J and Yanez, Erika and Traub, Elizabeth and Joyce, Allison and Marutani, Amy and Green, Nicole and Balter, Sharon and Poitier, Sheree R and King, Jan},
title = {Use of Baloxavir Marboxil Post-Exposure Prophylaxis to Halt an Influenza A(H3) Outbreak in a College Sports Team, November 2024},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciaf148}
}
EUVIMED